Literature DB >> 25093936

Complete genome sequence of the gram-negative probiotic Escherichia coli strain Nissle 1917.

Marten Reister1, Klaus Hoffmeier2, Nicolas Krezdorn3, Bjoern Rotter4, Chunguang Liang5, Stefan Rund6, Thomas Dandekar7, Ulrich Sonnenborn8, Tobias A Oelschlaeger9.   

Abstract

Escherichia coli strain Nissle 1917 (EcN) is the active principle of a probiotic preparation (trade name Mutaflor(®)) used for the treatment of patients with intestinal diseases such as ulcerative colitis and diarrhea. It has GRAS (generally recognized as save) status and has been shown to be a therapeutically effective drug (Sonnenborn and Schulze, 2009). The complete genomic DNA sequence will help in identifying genes and their products which are essential for the strains probiotic nature. Genbank/EMBL/DDBJ accession number: CP007799 (chromosome).
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Escherichia coli Nissle 1917; Genome DNA sequence; Probiotic drug

Mesh：

Substances：

Year:  2014        PMID： 25093936     DOI： 10.1016/j.jbiotec.2014.07.442

Source DB:  PubMed          Journal:  J Biotechnol        ISSN： 0168-1656            Impact factor:   3.307


  35 in total

1.  Escherichia coli responds to environmental changes using enolasic degradosomes and stabilized DicF sRNA to alter cellular morphology.

Authors:  Oleg N Murashko; Sue Lin-Chao
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-05       Impact factor: 11.205

2.  CRISPR-based curing and analysis of metabolic burden of cryptic plasmids in Escherichia coli Nissle 1917.

Authors:  Halimatun S Zainuddin; Yanfen Bai; Thomas J Mansell
Journal:  Eng Life Sci       Date:  2019-06-03       Impact factor: 2.678

3.  Antimicrobial Peptide Conformation as a Structural Determinant of Omptin Protease Specificity.

Authors:  John R Brannon; Jenny-Lee Thomassin; Samantha Gruenheid; Hervé Le Moual
Journal:  J Bacteriol       Date:  2015-09-08       Impact factor: 3.490

4.  Adaptive Strategies of the Candidate Probiotic E. coli Nissle in the Mammalian Gut.

Authors:  Nathan Crook; Aura Ferreiro; Andrew J Gasparrini; Mitchell W Pesesky; Molly K Gibson; Bin Wang; Xiaoqing Sun; Zevin Condiotte; Stephen Dobrowolski; Daniel Peterson; Gautam Dantas
Journal:  Cell Host Microbe       Date:  2019-03-26       Impact factor: 21.023

5.  Comparative Pathogenomics of Escherichia coli: Polyvalent Vaccine Target Identification through Virulome Analysis.

Authors:  J R Clark; A M Maresso
Journal:  Infect Immun       Date:  2021-07-15       Impact factor: 3.441

6.  The prediction of virulence based on presence of virulence genes in E. coli may not always be accurate.

Authors:  Trudy M Wassenaar; Florian Gunzer
Journal:  Gut Pathog       Date:  2015-06-19       Impact factor: 4.181

Review 7.  Are probiotics or prebiotics useful in pediatric irritable bowel syndrome or inflammatory bowel disease?

Authors:  Stefano Guandalini
Journal:  Front Med (Lausanne)       Date:  2014-08-28

8.  Genetic Analysis and Detection of fliC H1 and fliC H12 Genes Coding for Serologically Closely Related Flagellar Antigens in Human and Animal Pathogenic Escherichia coli.

Authors:  Lothar Beutin; Sabine Delannoy; Patrick Fach
Journal:  Front Microbiol       Date:  2016-02-15       Impact factor: 5.640

Review 9.  Sialidases from gut bacteria: a mini-review.

Authors:  Nathalie Juge; Louise Tailford; C David Owen
Journal:  Biochem Soc Trans       Date:  2016-02       Impact factor: 5.407

Review 10.  Forty Years of Oxalobacter formigenes, a Gutsy Oxalate-Degrading Specialist.

Authors:  Steven L Daniel; Luke Moradi; Henry Paiste; Kyle D Wood; Dean G Assimos; Ross P Holmes; Lama Nazzal; Marguerite Hatch; John Knight
Journal:  Appl Environ Microbiol       Date:  2021-08-26       Impact factor: 4.792
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.